Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 113.48
(-0.65%)
CNY 113.48
(-0.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 35.74 Million CNY | -13.2% |
| 2022 | 41.18 Million CNY | -10.09% |
| 2021 | 45.8 Million CNY | 147.48% |
| 2020 | 18.5 Million CNY | 416.91% |
| 2019 | 3.58 Million CNY | 170.58% |
| 2018 | 1.32 Million CNY | 40.29% |
| 2017 | 943.26 Thousand CNY | 32.26% |
| 2016 | 713.21 Thousand CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 32.86 Million CNY | -8.05% |
| 2024 Q2 | 30.08 Million CNY | -8.48% |
| 2024 Q3 | 11.73 Million CNY | -51.56% |
| 2023 Q4 | 35.74 Million CNY | -9.24% |
| 2023 FY | 35.74 Million CNY | -13.2% |
| 2023 Q3 | 39.38 Million CNY | -12.51% |
| 2023 Q2 | 45.01 Million CNY | 17.48% |
| 2023 Q1 | 38.31 Million CNY | -6.95% |
| 2022 Q4 | 41.18 Million CNY | 6.25% |
| 2022 Q3 | 38.75 Million CNY | -11.07% |
| 2022 Q2 | 43.58 Million CNY | 1.2% |
| 2022 Q1 | 43.06 Million CNY | -5.97% |
| 2022 FY | 41.18 Million CNY | -10.09% |
| 2021 FY | 45.8 Million CNY | 147.48% |
| 2021 Q1 | 17.36 Million CNY | 0.0% |
| 2021 Q2 | 49.98 Million CNY | 187.82% |
| 2021 Q3 | 47.75 Million CNY | -4.46% |
| 2021 Q4 | 45.8 Million CNY | -4.08% |
| 2020 Q1 | 3.58 Million CNY | 0.0% |
| 2020 Q4 | - CNY | -100.0% |
| 2020 Q3 | 4.42 Million CNY | 22.83% |
| 2020 Q2 | 3.6 Million CNY | 0.57% |
| 2020 FY | 18.5 Million CNY | 416.91% |
| 2019 Q4 | 3.58 Million CNY | 93.07% |
| 2019 Q3 | 1.85 Million CNY | 16.63% |
| 2019 FY | 3.58 Million CNY | 170.58% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 1.59 Million CNY | 0.0% |
| 2018 Q4 | 1.32 Million CNY | 0.0% |
| 2018 FY | 1.32 Million CNY | 40.29% |
| 2017 FY | 943.26 Thousand CNY | 32.26% |
| 2016 FY | 713.21 Thousand CNY | 0.0% |